Advisory Committee on Immunization Practices (ACIP), 4911 [2011-1737]

Download as PDF Federal Register / Vol. 76, No. 18 / Thursday, January 27, 2011 / Notices 4911 DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2011–1742 Filed 1–26–11; 8:45 am] Dated: January 20, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. BILLING CODE 4163–18–P [FR Doc. 2011–1737 Filed 1–26–11; 8:45 am] Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Building Capacity for State-Based Occupational Health Surveillance, Program Announcement PAR 10–188, Initial Review Dated: January 20, 2011. Carol E. Walker, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. BILLING CODE 4160–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) mstockstill on DSKH9S0YB1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting of the aforementioned committee: Times and Dates: 8 a.m.–6 p.m., February 23, 2011. 8 a.m.–5 p.m., February 24, 2011. Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton Road, NE., Building 19, Kent ‘‘Oz’’ Nelson Auditorium, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Purpose: The committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines. Matters To Be Discussed: The agenda will include discussions on: immunization of healthcare personnel; Japanese encephalitis vaccine; 13-valent pneumococcal conjugate vaccine; human papillomavirus (HPV) vaccines; human immunodeficiency virus (HIV); hepatitis B vaccine; pertussis vaccine; influenza; herpes zoster vaccine. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Stephanie B. Thomas, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road, NE., Mailstop E–05, Atlanta, Georgia 30333, Telephone: (404) 639–8836, Fax: (404) 639–8905, e-mail acip@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. VerDate Mar<15>2010 17:51 Jan 26, 2011 Jkt 223001 Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Centers of Excellence To Promote a Healthier Workforce, Request for Applications (RFA) OH11–001, Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Times and Dates: 8 a.m.–5 p.m., March 23, 2011 (Closed). 8 a.m.–5 p.m., March 24, 2011 (Closed). 8 a.m.–5 p.m., March 25, 2011 (Closed). Place: Embassy Suites, 1900 Diagonal Road, Alexandria, Virginia 22314, Telephone: (703) 684–5900. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Centers of Excellence to Promote a Healthier Workforce, RFA OH11– 001.’’ Contact Person for More Information: George Bockosh, PhD, Scientific Review Officer, Office of Extramural Programs, National Institute for Occupational Safety and Health, CDC, 1600 Clifton Road, NE., Mailstop P05, Atlanta Georgia 30333, Telephone: (412) 833–0874. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Dated: January 20, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–1736 Filed 1–26–11; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 Centers for Disease Control and Prevention In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Times and Dates: 10 a.m.–11:30 a.m., February 15, 2011 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Building Capacity for StateBased Occupational Health Surveillance, PAR 10–188.’’ Contact Person for More Information: M. Chris Langub, PhD, Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E74, Atlanta, Georgia 30333, Telephone (404) 498–2543. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Dated: January 19, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–1734 Filed 1–26–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Occupational Safety and Health Educational Research Centers, Program Announcement PAR 10–217, Initial Review In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: E:\FR\FM\27JAN1.SGM 27JAN1

Agencies

[Federal Register Volume 76, Number 18 (Thursday, January 27, 2011)]
[Notices]
[Page 4911]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-1737]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following meeting of the aforementioned 
committee:

    Times and Dates:
    8 a.m.-6 p.m., February 23, 2011.
    8 a.m.-5 p.m., February 24, 2011.
    Place: CDC, Tom Harkin Global Communications Center, 1600 
Clifton Road, NE., Building 19, Kent ``Oz'' Nelson Auditorium, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters To Be Discussed: The agenda will include discussions on: 
immunization of healthcare personnel; Japanese encephalitis vaccine; 
13-valent pneumococcal conjugate vaccine; human papillomavirus (HPV) 
vaccines; human immunodeficiency virus (HIV); hepatitis B vaccine; 
pertussis vaccine; influenza; herpes zoster vaccine. Agenda items 
are subject to change as priorities dictate.
    Contact Person for More Information: Stephanie B. Thomas, 
National Center for Immunization and Respiratory Diseases, CDC, 1600 
Clifton Road, NE., Mailstop E-05, Atlanta, Georgia 30333, Telephone: 
(404) 639-8836, Fax: (404) 639-8905, e-mail acip@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention, 
and the Agency for Toxic Substances and Disease Registry.

    Dated: January 20, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-1737 Filed 1-26-11; 8:45 am]
BILLING CODE 4160-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.